Takahito Hara

2.2k total citations
51 papers, 1.7k citations indexed

About

Takahito Hara is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Takahito Hara has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 24 papers in Pulmonary and Respiratory Medicine and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Takahito Hara's work include Prostate Cancer Treatment and Research (21 papers), Hormonal and reproductive studies (15 papers) and Ubiquitin and proteasome pathways (7 papers). Takahito Hara is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Hormonal and reproductive studies (15 papers) and Ubiquitin and proteasome pathways (7 papers). Takahito Hara collaborates with scholars based in Japan, United States and Canada. Takahito Hara's co-authors include Masuo Yamaoka, Masami Kusaka, Hideo Araki, Naoyuki Kanzaki, Jun‐ichi Miyazaki, Masaomi Miyamoto, Akihiro Tasaka, Tomohiro Kaku, Megumi Morimoto and Yoshinori Satomi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Takahito Hara

50 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahito Hara Japan 24 819 757 456 430 347 51 1.7k
Masami Kusaka Japan 25 715 0.9× 1.1k 1.4× 431 0.9× 488 1.1× 453 1.3× 47 2.2k
S. Elaine Barrie United Kingdom 16 564 0.7× 564 0.7× 362 0.8× 216 0.5× 265 0.8× 25 1.3k
Samedy Ouk United States 9 1.5k 1.8× 728 1.0× 466 1.0× 601 1.4× 370 1.1× 11 2.1k
Teresa Wasielewska United States 6 1.4k 1.7× 652 0.9× 413 0.9× 494 1.1× 372 1.1× 7 1.8k
Elzbieta Kawinski United States 11 886 1.1× 941 1.2× 303 0.7× 305 0.7× 321 0.9× 14 2.0k
Andrew Kwon United States 3 1.6k 2.0× 818 1.1× 467 1.0× 579 1.3× 415 1.2× 5 2.1k
Mark Titus United States 24 1.3k 1.6× 695 0.9× 745 1.6× 561 1.3× 373 1.1× 62 2.1k
Alison Reid United Kingdom 18 1.9k 2.3× 894 1.2× 750 1.6× 754 1.8× 409 1.2× 34 2.7k
John E. Monahan United States 12 561 0.7× 918 1.2× 192 0.4× 306 0.7× 223 0.6× 18 1.6k
O. Harris Ford United States 12 1.3k 1.5× 876 1.2× 582 1.3× 394 0.9× 471 1.4× 16 1.8k

Countries citing papers authored by Takahito Hara

Since Specialization
Citations

This map shows the geographic impact of Takahito Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahito Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahito Hara more than expected).

Fields of papers citing papers by Takahito Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahito Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahito Hara. The network helps show where Takahito Hara may publish in the future.

Co-authorship network of co-authors of Takahito Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Takahito Hara. A scholar is included among the top collaborators of Takahito Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahito Hara. Takahito Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamaguchi, Naoya, et al.. (2021). Pharmacological properties and clinical outcomes of the anti-cancer drug, cabozantinib (CABOMETYX<sup>®</sup>). Folia Pharmacologica Japonica. 156(5). 303–311.
2.
Nishizawa, Satoru, Hiroyuki Sumi, Yoshihiko Satoh, et al.. (2017). In vitro and in vivo antitumor activities of T-3764518, a novel and orally available small molecule stearoyl-CoA desaturase 1 inhibitor. European Journal of Pharmacology. 807. 21–31. 22 indexed citations
3.
Morimoto, Megumi, Yuichiro Amano, Masahiro Oka, et al.. (2017). Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f. PLoS ONE. 12(12). e0189480–e0189480. 16 indexed citations
4.
Arita, Takeo, Megumi Morimoto, Yukiko Yamamoto, et al.. (2017). Prolyl-tRNA synthetase inhibition promotes cell death in SK-MEL-2 cells through GCN2-ATF4 pathway activation. Biochemical and Biophysical Research Communications. 488(4). 648–654. 16 indexed citations
5.
Nakata, Daisuke, Kazuhide Nakayama, Shinsuke Araki, et al.. (2016). The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation. Biochemical and Biophysical Research Communications. 483(1). 271–276. 48 indexed citations
6.
Aikawa, Katsuji, Takenori Hitaka, Yumi Imai, et al.. (2015). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I. Bioorganic & Medicinal Chemistry. 23(10). 2568–2578. 19 indexed citations
7.
Yamaoka, Masuo, et al.. (2015). Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile. European Journal of Pharmacology. 765. 322–331. 16 indexed citations
8.
Okegawa, Takatsugu, et al.. (2013). Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene. Oncogenesis. 2(7). e58–e58. 29 indexed citations
9.
Yamaoka, Masuo, Takahito Hara, Takenori Hitaka, et al.. (2012). Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. The Journal of Steroid Biochemistry and Molecular Biology. 129(3-5). 115–128. 98 indexed citations
10.
Hara, Takahito, Tomohiro Kaku, Toshiyuki Takeuchi, et al.. (2012). Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats. The Journal of Steroid Biochemistry and Molecular Biology. 134. 80–91. 28 indexed citations
11.
Yamamoto, Satoshi, Nobuyuki Matsunaga, Takenori Hitaka, et al.. (2011). Design, synthesis, and biological evaluation of 4-phenylpyrrole derivatives as novel androgen receptor antagonists. Bioorganic & Medicinal Chemistry. 20(1). 422–434. 18 indexed citations
12.
Kaku, Tomohiro, Takenori Hitaka, Akio Ojida, et al.. (2011). Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer. Bioorganic & Medicinal Chemistry. 19(21). 6383–6399. 103 indexed citations
13.
Miyakawa, Yozo, Takahito Hara, & Y. Iimura. (2009). Establishment of a screening system for essential genes from the pathogenic yeastCandida glabrata: identification of a putativeTEM1homologue. Letters in Applied Microbiology. 49(3). 317–323. 1 indexed citations
14.
15.
Hara, Takahito, Hideyo Miyazaki, Aram Lee, Chau P. Tran, & Robert E. Reiter. (2008). Androgen Receptor and Invasion in Prostate Cancer. Cancer Research. 68(4). 1128–1135. 98 indexed citations
16.
Matsunaga, Nobuyuki, Tomohiro Kaku, Akio Ojida, et al.. (2004). C17,20-lyase inhibitors. Part 2: Design, synthesis and structure–activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors. Bioorganic & Medicinal Chemistry. 12(16). 4313–4336. 47 indexed citations
17.
Hara, Takahito, Akihiro Kume, Yutaka Hanazono, et al.. (2004). Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene. Gene Therapy. 11(18). 1370–1377. 2 indexed citations
18.
Hara, Takahito, Jun‐ichi Miyazaki, Hideo Araki, et al.. (2003). Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome.. PubMed. 63(1). 149–53. 353 indexed citations
19.
Kodama, T., Takahito Hara, Eri Okamoto, Yasuo Kusunoki, & Koso Ohama. (1998). Characteristic changes of large granular lymphocytes that strongly express CD56 in endometrium during the menstrual cycle and early pregnancy. Human Reproduction. 13(4). 1036–1043. 41 indexed citations
20.
Hara, Takahito, et al.. (1995). Site-directed mutagenesis of glutathione synthetase from Escherichia coli B: mapping of the  -L-glutamyl-L-cysteine-binding site. Protein Engineering Design and Selection. 8(7). 711–716. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026